The latest genitourinary oncology news
Anti-CTLA-4 antibody tremelimumab shows efficacy in patients with metastatic bladder cancer
Treatment with the investigational anti-CTLA-4 agent tremelimumab showed clinical responses in patients with pretreated metastatic…